Urgent Angiography Indication Assessment Tool in NSTE ACS
Clinical urgency assessment
Select Yes or No for each feature. This is a triage aid, not a validated numerical risk score.
7Features
Clinical interpretation
This tool separates features that support an immediate invasive strategy from selected high-risk findings that generally support early angiography. It does not calculate a validated score and should only be used in the context of a working diagnosis of NSTE-ACS.
Immediate invasive strategy
- Refractory or recurrent ischemic chest pain despite optimal medical therapy.
- Hemodynamic instability or cardiogenic shock.
- Electrical instability, including sustained ventricular arrhythmia.
- Acute pulmonary edema or heart failure related to ischemia.
- Worsening ischemic mitral regurgitation or suspected mechanical complication.
High-risk findings that support early angiography
- Ongoing dynamic ST-segment changes consistent with ischemia.
- A steep rise in serial troponin values despite optimized medical therapy.
- Integrate these findings with GRACE risk, serial ECG/troponin results, bleeding risk, comorbidities, and patient preference.
References
Rao SV, O'Donoghue ML, Ruel M, et al.2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2025.doi:10.1016/j.jacc.2024.11.009
Byrne RA, Rossello X, Coughlan JJ, et al.2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826.doi:10.1093/eurheartj/ehad191
Mehta SR, Granger CB, Boden WE, et al.Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360:2165–2175.doi:10.1056/NEJMoa0807986
Jobs A, Mehta SR, Montalescot G, et al.Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. Lancet. 2017;390:737–746.doi:10.1016/S0140-6736(17)31490-3
Clinical disclaimer: This decision-support tool is intended for qualified healthcare professionals and does not replace clinical judgment, local ACS protocols, cardiology consultation, or emergency transfer pathways. It is not intended for patients with clear STEMI, in whom the appropriate reperfusion pathway must proceed without delay. Consider procedural risks, renal function, bleeding risk, goals of care, and patient preferences without delaying life-saving treatment in an unstable patient.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.